These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13252969)

  • 1. [Resistance induced by tuberculosis vaccination by killed Koch bacilli with (V.D.S.) or without addition of spreading factor; comparison with BCG].
    DEGLI ESPOSTI A
    Lotta Tuberc; 1955; 25(5-6):250-70. PubMed ID: 13252969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity delimiting and slowing tuberculous foci assumed by mesenchymal tissues previously activated by killed Koch Bacilli with or without spreading factor, and by BCG].
    DEGLI ESPOSTI A
    Clin Pediatr (Bologna); 1954 Aug; 36(8):589-96. PubMed ID: 13219772
    [No Abstract]   [Full Text] [Related]  

  • 3. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. VI. Comparative effects of BCG, H37Ra, Mycobacterium phlei and a wax-protein fraction of human tubercle bacilli.
    Am J Hyg; 1955 Nov; 62(3):270-82. PubMed ID: 13268417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cellular-Koch bacillus interactions. Discovery of non-specific principles capable of augmenting cellular resistance].
    DELAUNAY A
    Vie Med; 1962 Feb; 43():261-8. PubMed ID: 13885077
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of BCG and urea-treated tubercle bacilli].
    AUFDERMAUR M; BRODHAGE H
    Schweiz Z Pathol Bakteriol; 1955; 18(6):1237-43. PubMed ID: 13337295
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antituberculosis vaccination in humans: comparison of killed and live bacilli vaccines].
    DE TONI G
    Minerva Med; 1953 Jun; 44(46):1531-40. PubMed ID: 13072086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fifty years of the history of antituberculosis killed-bacilli vaccination in humans].
    DE TONI G
    Minerva Med; 1953 Jun; 44(45):1503-12. PubMed ID: 13072081
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunisation of red mice against tuberculosis by vaccination with killed vaccines. I. Comparison of living BCG with various killed vaccines administered in aqueous and liquid paraffin suspensions.
    JESPERSEN A; MAGNUSSON M
    Acta Pathol Microbiol Scand; 1956; 39(6):431-45. PubMed ID: 13381491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Killed antituberculosis vaccine potentialized by diffusion factor in laboratory experiments].
    SALVIOLI G
    Minerva Med; 1953 Mar; 44(22):697-706. PubMed ID: 13071909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antituberculous vaccination with killed bacteria in the report of Santi and Azzolini; review and commentary].
    TARONNA S
    Clin Pediatr (Bologna); 1955 Oct; 37(10):780-8. PubMed ID: 13284958
    [No Abstract]   [Full Text] [Related]  

  • 11. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histopathological picture following intravenous inoculation into the guinea pig of living, attenuated Koch bacillus (BCG) or killed Koch bacillus Petragnani's integral anatuberculin)].
    CINTI G
    Sperimentale; 1950; 100(1-2):118-22. PubMed ID: 15424775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Latent allergy disclosed by the full bacillary bodies and antituberculous resistance brought about by the BCG vaccination].
    BRETEY J; NEGRE L
    Bull Acad Natl Med; 1956 Apr 17-24; 140(13-14):224-5. PubMed ID: 13364454
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SIGNIFICANCE OF THE SPREADING FACTOR IN THE PATHOGENESIS OF EXPERIMENTAL CUTANEOUS TUBERCULOSIS].
    IURINOV TM
    Vestn Dermatol Venerol; 1964 Oct; 38():40-3. PubMed ID: 14347229
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín.
    Palmer MV; Thacker TC; Waters WR
    Vaccine; 2007 Sep; 25(36):6589-97. PubMed ID: 17688976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Mycobacterium bovis Bacillus Calmette-Guérin in white-tailed deer (Odocoileus virginianus) after oral or parenteral vaccination.
    Palmer MV; Thacker TC; Waters WR; Robbe-Austerman S; Lebepe-Mazur SM; Harris NB
    Zoonoses Public Health; 2010 Dec; 57(7-8):e206-12. PubMed ID: 20707863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.